Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
198.52
-0.50 (-0.25%)
At close: Aug 31, 2026, 4:00 PM EDT
197.07
-1.45 (-0.73%)
Pre-market: Sep 1, 2026, 8:23 AM EDT
Axsome Therapeutics Employees
Axsome Therapeutics had 1,346 employees as of June 30, 2026. The number of employees increased by 500 or 59.10% compared to the same quarter last year.
Employees
1,346
Change
500
Growth
59.10%
Revenue / Employee
$576,946
Profits / Employee
-$142,380
Market Cap
10.40B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,346 | 500 | 59.10% |
| Mar 31, 2026 | 1,220 | 508 | 71.35% |
| Dec 31, 2025 | 925 | 242 | 35.43% |
| Sep 30, 2025 | 816 | 209 | 34.43% |
| Jun 30, 2025 | 846 | 257 | 43.63% |
| Mar 31, 2025 | 712 | 143 | 25.13% |
| Dec 31, 2024 | 683 | 138 | 25.32% |
| Sep 30, 2024 | 607 | 105 | 20.92% |
| Jun 30, 2024 | 589 | 167 | 39.57% |
| Mar 31, 2024 | 569 | 176 | 44.78% |
| Dec 31, 2023 | 545 | 162 | 42.30% |
| Sep 30, 2023 | 502 | 150 | 42.61% |
| Jun 30, 2023 | 422 | 224 | 113.13% |
| Mar 31, 2023 | 393 | 277 | 238.79% |
| Dec 31, 2022 | 383 | 275 | 254.63% |
| Sep 30, 2022 | 352 | 246 | 232.08% |
| Jun 30, 2022 | 198 | 105 | 112.90% |
| Mar 31, 2022 | 116 | 46 | 65.71% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,000 |
| Ionis Pharmaceuticals | 1,480 |
| Arrowhead Pharmaceuticals | 711 |
| Cytokinetics | 673 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
AXSM News
- 21 hours ago - Axsome pullback brings attractive entry point, says H.C. Wainwright - TheFly
- 1 day ago - Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation - GlobeNewsWire
- 15 days ago - Axsome Therapeutics price target raised to $316 from $306 at Mizuho - TheFly
- 20 days ago - Axsome Therapeutics price target lowered to $297 from $304 at RBC Capital - TheFly
- 21 days ago - Axsome Therapeutics price target raised to $251 from $242 at Morgan Stanley - TheFly
- 21 days ago - Axsome Therapeutics price target raised to $275 from $260 at Guggenheim - TheFly
- 21 days ago - Axsome Therapeutics price target raised to $256 from $255 at Wells Fargo - TheFly
- 22 days ago - Axsome Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts